The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) are jointly recruiting a full-time faculty member at the Assistant Professor or Associate Professor level without tenure due to funding (WOT), commensurate with experience and qualifications in the Translational Science & Therapeutics Division of the Fred Hutch and the Department of Laboratory Medicine & Pathology (DLMP), School of Medicine at the UW. This position would have an annual service period of 12 months [July 1-June 30]. The primary appointment will be in the Translational Science & Therapeutics Division of Fred Hutch.
The selected individual for the advertised position is expected to contribute to our mission of delivering outstanding clinical care and developing excellence in clinical research in anatomic pathology/clinical pathology. We seek candidates with expertise in hematopathology and molecular pathology and with interest and experience in pathology related to stem cell transplant and immunotherapy. Interest and expertise in pathology and genomics of lymphoid neoplasms would be preferred. Based on the qualifications, this position could entail a leadership role as medical director of a laboratory location. The person may also have an opportunity to participate in deep immunophenotyping and cell sorting for genomic investigations. Fred Hutch and University of Washington faculty engage in teaching, research, and service. Teaching responsibilities will involve the delivery of informal teaching sessions and formal lectures to providers and the general medical community.
Faculty are expected to perform their primary activities on-site at Fred Hutch.
Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
Anticipated Start Date: FY26 (July 1, 2025 – June 30, 2026)